Kolinsky Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$619K Buy
2,376
+135
+6% +$40.1K 0.38% 54
2024
Q3
$722K Buy
2,241
+95
+4% +$31.1K 0.47% 38
2024
Q2
$671K Buy
2,146
+268
+14% +$78.7K 0.48% 40
2024
Q1
$534K Buy
1,878
+4
+0.2% +$1.17K 0.41% 56
2023
Q4
$540K Buy
1,874
+201
+12% +$54.8K 0.48% 46
2023
Q3
$450K Buy
1,673
+11
+0.7% +$2.75K 0.45% 48
2023
Q2
$368K Buy
1,662
+535
+47% +$124K 0.35% 73
2023
Q1
$272K Sell
1,127
-21
-2% -$5.16K 0.29% 89
2022
Q4
$302K Buy
1,148
+86
+8% +$23.1K 0.34% 73
2022
Q3
$239K Buy
1,062
+13
+1% +$3.15K 0.3% 93
2022
Q2
$255K Buy
1,049
+71
+7% +$17.4K 0.3% 86
2022
Q1
$236K Buy
+978
New +$225K 0.23% 113

Other funds holding AMGN

Kolinsky Wealth Management's AMGN Position: Q4 2024 in Review

Kolinsky Wealth Management increased its Amgen (AMGN) stake by 6% in Q4 2024, buying an estimated $40.1K and bringing the position to 2,376 shares worth $619K. The position accounts for 0.38% of the portfolio, ranked #54.

Kolinsky Wealth Management first reported a position in AMGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $722K in Q3 2024. 2,860 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Kolinsky Wealth Management held 2,376 shares of Amgen worth $619K as of Q4 2024.
  • Kolinsky Wealth Management bought 135 Amgen shares in Q4 2024, an estimated $40.1K.
  • Amgen made up 0.38% of Kolinsky Wealth Management's portfolio in Q4 2024, its #54 holding.
  • Kolinsky Wealth Management first reported a position in Amgen in Q1 2022 and has held it in 12 quarters since.
  • Kolinsky Wealth Management's Amgen position peaked at $722K in Q3 2024.
  • 2,860 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Kolinsky Wealth Management's 13F filing for Q4 2024, filed 18 Feb 2025.